GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Minsheng Healthcare Co Ltd (SZSE:301507) » Definitions » EPS (Diluted)

Hangzhou Minsheng Healthcare Co (SZSE:301507) EPS (Diluted) : ¥0.25 (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Hangzhou Minsheng Healthcare Co EPS (Diluted)?

Hangzhou Minsheng Healthcare Co's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was ¥0.17. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.25.

Hangzhou Minsheng Healthcare Co's EPS (Basic) for the three months ended in Mar. 2024 was ¥0.17. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.25.

Hangzhou Minsheng Healthcare Co's EPS without NRI for the three months ended in Mar. 2024 was ¥0.17. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.26.

During the past 12 months, Hangzhou Minsheng Healthcare Co's average EPS without NRIGrowth Rate was -21.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Hangzhou Minsheng Healthcare Co EPS (Diluted) Historical Data

The historical data trend for Hangzhou Minsheng Healthcare Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Minsheng Healthcare Co EPS (Diluted) Chart

Hangzhou Minsheng Healthcare Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial - - 0.27 0.30 0.29

Hangzhou Minsheng Healthcare Co Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.05 0.03 - 0.17

Competitive Comparison of Hangzhou Minsheng Healthcare Co's EPS (Diluted)

For the Drug Manufacturers - General subindustry, Hangzhou Minsheng Healthcare Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Minsheng Healthcare Co's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hangzhou Minsheng Healthcare Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Hangzhou Minsheng Healthcare Co's PE Ratio falls into.



Hangzhou Minsheng Healthcare Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Hangzhou Minsheng Healthcare Co's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(85.634-0)/295.289
=0.29

Hangzhou Minsheng Healthcare Co's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(58.872-0)/346.307
=0.17

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Minsheng Healthcare Co  (SZSE:301507) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Hangzhou Minsheng Healthcare Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Hangzhou Minsheng Healthcare Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Minsheng Healthcare Co (SZSE:301507) Business Description

Traded in Other Exchanges
N/A
Address
No. 101, Xintian Road, Donghu Street, Linping, Zhejiang, Hangzhou, CHN, 311100
Hangzhou Minsheng Healthcare Co Ltd focuses on the field of vitamin and mineral supplements and is a high-tech enterprise integrating research and development, production and sales of vitamin and mineral over-the-counter drugs and health food. The company's current main product is 21 Golden Vita multi-dimensional element tablets (21).

Hangzhou Minsheng Healthcare Co (SZSE:301507) Headlines

No Headlines